IP Library Granted Patent US 9,862,724
Granted Patent B2
US 9,862,724 · App. 15/145,435 · Granted Jan 9, 2018

Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use

Inventors: Yingzhi Bi (Plainsboro, NJ); Michael Walter Gardyan (Feasterville, PA); Michael Alan Green (Easton, PA); Godwin Kumi (Rocky Hill, CT); Yulian Zhang (Acton, MA)
Assignee: Lexicon Pharmaceuticals, Inc.
C07D487/04A61K31/519
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,862,724
App. No.
15/145,435
Granted
Jan 9, 2018
Kind
B2
Abstract

Pyrazolo[1,5-a]pyrimidine-based compounds of the formula: are disclosed, wherein R 1 , R 2 and R 3 are defined herein. Compositions comprising the compounds and methods of their use to treat, manage and/or prevent diseases and disorders mediated by mediated by adaptor associated kinase 1 activity are also disclosed.

Claims (22)

1. A compound of the formula:

or a pharmaceutically acceptable salt thereof, wherein:

X is CH or N;

each R 1A is independently —OR 1C , —N(R 1C ) 2 , —C(O)R 1C , —C(O)OR 1C , —C(O)N(R 1C ) 2 , —N(R 1C )C(O)OR 1C , cyano, halo, or optionally substituted C 1-12 hydrocarbyl or 2-12-membered heterocarbyl, which optional substitution is with one or more RIB;

each R 1B is independently —OR 1C , —N(R 1C ) 2 , —C(O)R 1C , —C(O)OR 1C , —C(O)N(R 1C ) 2 , —N(R 1C )C(O)OR 1C , cyano or halo;

each R 1C is independently hydrogen or optionally substituted C 1-12 hydrocarbyl or 2-12-membered heterocarbyl, which optional substitution is with one or more of cyano, halo or hydroxyl;

each R 2C is independently —OR 2D , —N(R 2D ) 2 , —C(O)R 2D , —C(O)OR 2D , —C(O)N(R 2D ) 2 , —N(R 2D )C(O)OR 2D , cyano, halo, oxo, or optionally substituted C 1-22 hydrocarbyl or 2-12-membered heterocarbyl, which optional substitution is with one or more amino, cyano, halo, hydroxyl, or R 2D ;

each R 2D is independently hydrogen or optionally substituted C 1-12 hydrocarbyl or 2-12-membered heterocarbyl, which optional substitution is with one or more of amino, cyano, halo, hydroxyl;

n is 1-3; and

m is 0-3.

2. The compound of claim 1 , which is of the formula:

3. The compound of claim 1 , wherein X is N and m is 1 or 2.

4. The compound of claim 2 , which is of the formula:

5. The compound of claim 4 , which is of the formula:

6. The compound of claim 4 , which is of the formula:

7. The compound of claim 1 , wherein at least one R 1A ; is halo.

8. The compound of claim 1 , wherein at least one R 1A is —OR 1C .

9. The compound of claim 8 , wherein R 1C is optionally substituted C 1-12 hydrocarbyl.

10. The compound of claim 1 , wherein R 2C is optionally substituted C 1-6 hydrocarbyl.

11. The compound of claim 1 , wherein each R 2D is independently hydrogen or C 1-12 hydrocarbyl.

12. The compound of claim 1 , wherein at least one R 2D is optionally substituted C 1-12 hydrocarbyl, which optional substitution is with one or more of amino, cyano, halo, hydroxyl.

13. The compound of claim 1 , wherein R 2D is 2-12-membered heterocarbyl comprising at least one nitrogen atom.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded May 5, 2026
From: OXFORD FINANCE LLC
To: LEXICON PHARMACEUTICALS, INC.; LEXICON PHARMACEUTICALS
Reel/Frame 075545/0601 →
SECURITY INTEREST Recorded May 4, 2026
From: LEXICON PHARMACEUTICALS, INC.; LEXICON PHARMACEUTICALS (NEW JERSEY), INC.; LION ACQUISITION CORPORATION
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 075498/0899 →
SECURITY INTEREST Recorded Mar 17, 2022
From: LEXICON PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 059432/0709 →
Continuity (3)
Continuation 14478089 · Sep 5, 2014
Provisional Application 61874395 · Sep 6, 2013
Related Publication 20170081330A1 · Mar 23, 2017